1. Home
  2. LAES vs OVID Comparison

LAES vs OVID Comparison

Compare LAES & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEALSQ Corp

LAES

SEALSQ Corp

HOLD

Current Price

$3.13

Market Cap

606.5M

Sector

Technology

ML Signal

HOLD

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$2.57

Market Cap

522.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAES
OVID
Founded
2022
2014
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
606.5M
522.6M
IPO Year
2022
2017

Fundamental Metrics

Financial Performance
Metric
LAES
OVID
Price
$3.13
$2.57
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$4.00
$4.60
AVG Volume (30 Days)
19.1M
2.4M
Earning Date
03-31-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.90
EPS
N/A
N/A
Revenue
N/A
$7,252,000.00
Revenue This Year
$93.36
N/A
Revenue Next Year
$43.06
$19.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1181.27
52 Week Low
$1.99
$0.30
52 Week High
$8.71
$3.11

Technical Indicators

Market Signals
Indicator
LAES
OVID
Relative Strength Index (RSI) 47.77 55.36
Support Level $2.94 $2.56
Resistance Level $3.38 $2.74
Average True Range (ATR) 0.26 0.17
MACD -0.02 0.03
Stochastic Oscillator 28.95 90.87

Price Performance

Historical Comparison
LAES
OVID

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America, while it also has its presence in Europe, Middle East & Africa, Asia Pacific, and Latin America.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: